Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 107012 for the Development of Org 36286 (Corifollitropin Alfa)
Brief Summary: The objective of this follow-up study is to evaluate whether corifollitropin alfa (Org 36286) treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS) prior to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) is safe for pregnant participants and their offspring.


Options:
A: Arm Label: corifollitropin alfa + recFSH Mothers; Type: N/A; Interventions: Drug: corifollitropin alfa, Biological: recombinant Follicle Stimulating Hormone (recFSH), Biological: hCG Bolus injection | Arm Label: corifollitropin alfa + hCG Mothers; Type: N/A; Interventions: Drug: corifollitropin alfa, Biological: human Chorion Gonadotropin (hCG), Biological: hCG Bolus injection | Intervention Type: DRUG; Name: corifollitropin alfa; Assigned to Arm(s): corifollitropin alfa + hCG Mothers, corifollitropin alfa + recFSH Mothers | Intervention Type: BIOLOGICAL; Name: recombinant Follicle Stimulating Hormone (recFSH); Assigned to Arm(s): corifollitropin alfa + recFSH Mothers | Intervention Type: BIOLOGICAL; Name: human Chorion Gonadotropin (hCG); Assigned to Arm(s): corifollitropin alfa + hCG Mothers | Intervention Type: BIOLOGICAL; Name: hCG Bolus injection; Assigned to Arm(s): corifollitropin alfa + hCG Mothers, corifollitropin alfa + recFSH Mothers
B: Arm Label: Corifollitropin alfa 100 μg; Type: N/A; Interventions: Drug: Corifollitropin alfa, Drug: gonadatropin releasing hormone (GnRH) antagonist ganirelix, Biological: human chorion gonadotropin (hCG), Biological: progesterone, Drug: placebo-recFSH (follitropin beta), Biological: open-label recFSH (follitropin beta) | Arm Label: recFSH 150 IU; Type: N/A; Interventions: Biological: recFSH (follitropin beta), Drug: gonadatropin releasing hormone (GnRH) antagonist ganirelix, Biological: human chorion gonadotropin (hCG), Biological: progesterone, Drug: placebo-corifollitropin alfa, Biological: open-label recFSH (follitropin beta) | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): Corifollitropin alfa 100 μg | Intervention Type: BIOLOGICAL; Name: recFSH (follitropin beta); Assigned to Arm(s): recFSH 150 IU | Intervention Type: DRUG; Name: gonadatropin releasing hormone (GnRH) antagonist ganirelix; Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU | Intervention Type: BIOLOGICAL; Name: human chorion gonadotropin (hCG); Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU | Intervention Type: BIOLOGICAL; Name: progesterone; Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU | Intervention Type: DRUG; Name: placebo-recFSH (follitropin beta); Assigned to Arm(s): Corifollitropin alfa 100 μg | Intervention Type: DRUG; Name: placebo-corifollitropin alfa; Assigned to Arm(s): recFSH 150 IU | Intervention Type: BIOLOGICAL; Name: open-label recFSH (follitropin beta); Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU
C: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 (corifollitropin alfa) | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: Placebo | Arm Label: Experimental Group 3; Type: N/A; Interventions: Drug: Org 36286 (corifollitropin alfa) | Arm Label: Experimental Group 4; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286 (corifollitropin alfa); Assigned to Arm(s): Experimental Group 1, Experimental Group 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Experimental Group 2 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 4
D: Arm Label: Mothers Corifollitropin Alfa 150 µg; Type: N/A; Interventions: Drug: Corifollitropin Alfa 150 μg, Drug: Placebo for RecFSH/Follitropin beta, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: Mothers recFSH 200 IU; Type: N/A; Interventions: Biological: 200 IU RecFSH/Follitropin beta (Days 1 to 7), Drug: Placebo for Corifollitropin Alfa, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin Alfa 150 μg; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 1 to 7); Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for Corifollitropin Alfa; Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for RecFSH/Follitropin beta; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 8 to hCG); Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU

Answer: B